Daiichi Sankyo
Dan Switzer possesses extensive experience in the pharmaceutical industry, currently serving as the Head of the US Oncology Business Division at Daiichi Sankyo, Inc., since June 2005. With a progressive career at Daiichi Sankyo, Dan has held several key positions including Vice President of Marketing, Executive Director of US Marketing, and various leadership roles within the Pain and Hypertension Franchises. Prior to joining Daiichi Sankyo, Dan contributed to the field as a Consultant at Michael Allen Company from June 2000 to May 2005. Dan is an alumnus of Cornell University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.